Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.
about
Topical treatment of glaucoma: established and emerging pharmacology.Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.A Review of Nitric Oxide for the Treatment of Glaucomatous Disease.Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension.
P2860
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@en
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@nl
type
label
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@en
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@nl
prefLabel
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@en
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@nl
P2093
P2860
P1433
P1476
Long-term Safety and Efficacy ...... pertension: The JUPITER Study.
@en
P2093
JUPITER Study Group
Jason L Vittitow
Kazuhide Kawase
Makoto Araie
P2860
P2888
P304
P356
10.1007/S12325-016-0385-7
P407
P577
2016-07-25T00:00:00Z